Rare Disease Trial, Recruiting NCT02432625 Sponsor: Baylor College of Medicine Condition: Rare Disease
Back to Rare Disease

Rare Disease Trial, Recruiting

NCT02432625
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

General Natural History Study:

  • People who have been diagnosed with Osteogenesis Imperfecta (OI, also known as "brittle bone disease") confirmed through DNA testing
  • People whose medical history and bone X-rays strongly suggest OI, even if it has not been confirmed through lab or DNA testing

Vertebral (Spine) Compression Fractures Component:

  • People of any age who have a specific type of genetic change (called a nonsense or frameshift mutation) in the COL1A1 or COL1A2 genes, and show signs of OI Type I

Scoliosis (Curved Spine) Component:

  • Study participants between the ages of 3 and 17 years
  • Study participants aged 18 and older who have scoliosis

Dental and Craniofacial (Teeth and Face/Skull) Component:

  • People aged 3 years and older who are already enrolled in the main study

Pregnancy Component:

  • Women of childbearing age who have a genetic mutation in any known gene linked to OI, and who are considering becoming pregnant within 5 years of joining the main study
  • Women who are already pregnant and have had a bone density measurement taken within the 5 years before their first pregnancy visit in the study

Who may not be able to join:

General Natural History Study:

  • People who are not able to return for scheduled follow-up visits
  • People who have a bone or skeletal growth condition other than OI
  • People who have OI alongside a second separate genetic or syndrome-based diagnosis

Vertebral Compression Fractures Component:

  • People who have used bone-affecting medications (such as bisphosphonates, calcitonin, calcitriol, or fluoride) within the year before joining this part of the study
  • People who have conditions other than OI that affect muscle or bone development, such as cerebral palsy or rickets
  • People whose specific genetic mutation is located in the final coding sections of the COL1A1 or COL1A2 genes, as this type of mutation may not cause the particular form of OI this component is studying (confirm with trial site)

Dental and Craniofacial Component:

  • People who decline to have a dental examination

Pregnancy Component:

  • Males
  • Women who are approaching or have gone through menopause
  • Women who have previously been pregnant with three or more babies at the same time (higher-order multiples)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: V. Reid Sutton, M.D., Baylor College of Medicine

Phone: 713.798.6694

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2015
Est. completion
31 August 2030

Where this trial is recruiting

🇨🇦 Canada 🇺🇸 United States

Primary endpoints

Natural History of OI

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov